Gender‐Specific Effects of Oral Hypoglycemic Agents on Cancer Risk in Type 2 Diabetes Mellitus

ConclusionsOral insulin sensitizers, particularly thiazolidinedione, are associated with decreased malignancy risk in women with type 2 diabetes mellitus.

Source: Diabetes, Obesity and Metabolism - November 6, 2013 Category: Endocrinology Authors: Grace E. Ching Sun, Brian J. Wells, Kathleen Yip, Robert Zimmerman, Derek Raghavan, Michael W. Kattan, Sangeeta R. Kashyap Tags: Original Paper Source Type: research